Egg-Banking and Ovo-donation
Launched by INSTITUTO VALENCIANO DE INFERTILIDAD, IVI VALENCIA · Nov 4, 2008
Trial Information
Current as of May 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Receptors
- • Women receiving donor oocytes and whose partners without seere pathology of semen.
- • BMI \< 25
- Donors:
- Inclusion Criteria:
- • 18 - 35 years oldaños.
- • Normal Response (8-15 follicles)to long protocol of ovarian stimulation with hCG
- • Donors with normal menstrual cycles ( 21-35 day duration).
- • Donors with Body Mass Index (BMI) between 18-25 Kg/m2
- Exclusion Criteria:
- • Donors with +/= two previous miscarriages'
- • Polycystic Ovary Syndrome
- • Donors with antecedents of poor embrionary quality not attributed to masculine factor.
- • Donors with decline of Estradiol Hormone of more than 10% or Estradiol Hormone plateau.
- • Donors with a high response \>20 ovocitos and/or levels above 3000pg/mL of Estradiol the day of the administration of Chorionic gonadotropin (hCG.
About Instituto Valenciano De Infertilidad, Ivi Valencia
Instituto Valenciano de Infertilidad (IVI Valencia) is a leading fertility clinic and research institution dedicated to advancing reproductive health and assisted reproductive technologies. With a commitment to providing personalized care and innovative treatment options, IVI Valencia conducts clinical trials aimed at enhancing the understanding and effectiveness of infertility therapies. The institute combines state-of-the-art facilities with a team of experienced specialists, ensuring high standards of patient safety and ethical research practices. IVI Valencia plays a pivotal role in fostering scientific advancements in the field of reproductive medicine, ultimately striving to improve outcomes for individuals and couples facing fertility challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valencia, , Spain
Patients applied
Trial Officials
Ana Cobo, PhD
Principal Investigator
Instituto Valenciano de Infertilidad
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials